Differential expression of toll-like receptors in the human placenta across early gestation

Placenta

Volumn 46, Issue , 2016, Pages 1-10

  Pudney, Jeffrey ^a   He, Xianbao ^a   Masheeb, Zahrah ^a   Kindelberger, David W ^a   Kuohung, Wendy ^a   Ingalls, Robin R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Placenta; Pregnancy; Reproductive immunology; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ARTICLE; CHORION VILLUS; CONTROLLED STUDY; CYTOTROPHOBLAST; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; ANATOMY AND HISTOLOGY; FEMALE; GESTATIONAL AGE; METABOLISM; PREGNANCY;

CHORIONIC VILLI; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; TOLL-LIKE RECEPTORS;

EID: 84980406473     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2016.07.005     Document Type: Article

References (38)

1. [1] Land, W.G., How evolution tells us to induce allotolerance. Exp. Clin. Transpl. 13:Suppl 1 (2015), 46–54.
2. [2] Svensson-Arvelund, J., Ernerudh, J., The role of macrophages in promoting and maintaining homeostasis at the fetal-maternal interface. Am. J. Reprod. Immunol. 74:2 (2015), 100–109, 10.1111/aji.12357.
3. [3] Aagaard, K., Ma, J., Antony, K.M., Ganu, R., Petrosino, J., Versalovic, J., The placenta harbors a unique microbiome. Sci. Transl. Med., 6(237), 2014, 237ra65, 10.1126/scitranslmed.3008599 doi:6/237/237ra65 [pii].
4. [4] Cao, B., Stout, M.J., Lee, I., Mysorekar, I.U., Placental microbiome and its role in preterm birth. Neoreviews 15:12 (2014), e537–e545, 10.1542/neo.15-12-e537.
5. [5] Collado, M.C., Rautava, S., Aakko, J., Isolauri, E., Salminen, S., Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci. Rep., 6, 2016, 23129, 10.1038/srep23129.
6. [6] Dong, X.D., Li, X.R., Luan, J.J., Liu, X.F., Peng, J., Luo, Y.Y., Liu, C.J., Bacterial communities in neonatal feces are similar to mothers' placentae. Can. J. Infect. Dis. Med. Microbiol. 26:2 (2015), 90–94.
7. [7] Zheng, J., Xiao, X., Zhang, Q., Mao, L., Yu, M., Xu, J., The placental microbiome varies in association with low birth weight in full-term neonates. Nutrients 7:8 (2015), 6924–6937, 10.3390/nu7085315.
8. [8] Medzhitov, R., Janeway, C. Jr., Innate immunity. N. Engl. J. Med. 343:5 (2000), 338–344.
9. [9] Medzhitov, R., Janeway, C.A. Jr., Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:3 (1997), 295–298.
10. [10] Rock, F.L., Hardiman, G., Timans, J.C., Kastelein, R.A., Bazan, J.F., A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U. S. A. 95:2 (1998), 588–593.
11. [11] Morisato, D., Anderson, K.V., Signaling pathways that establish the dorsal-ventral pattern of the Drosophila embryo. Annu. Rev. Genet. 29 (1995), 371–399.
12. [12] Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M., Hoffmann, J.A., The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:6 (1996), 973–983.
13. [13] Akira, S., Mammalian toll-like receptors. Curr. Opin. Immunol., 15(2), 2003, 238.
14. [14] Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 124:4 (2006), 783–801.
15. [15] Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:5 (2010), 373–384, 10.1038/ni.1863.
16. [16] Lien, E., Ingalls, R.R., Toll-like receptors. Crit. Care Med. 30:1 Suppl (2002), S1–S11.
17. [17] O'Neill, L.A., The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE, 2000(44), 2000, RE1.
18. [18] Patni, S., Wynen, L.P., Seager, A.L., Morgan, G., White, J.O., Thornton, C.A., Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol. Reprod. 80:2 (2009), 243–248, 10.1095/biolreprod.108.069252 doi:biolreprod.108.069252 [pii].
19. [19] Tangerås, L.H., Stodle, G.S., Olsen, G.D., Leknes, A.H., Gundersen, A.S., Skei, B., Vikdal, A.J., Ryan, L., Steinkjer, B., Myklebost, M.F., Langaas, M., Austgulen, R., Iversen, A.C., Functional Toll-like receptors in primary first-trimester trophoblasts. J. Reprod. Immunol., 2014, 10.1016/j.jri.2014.04.004.
20. [20] Pudney, J., Anderson, D.J., Expression of toll-like receptors in genital tract tissues from normal and HIV-infected men. Am. J. Reprod. Immunol. 65:1 (2011), 28–43, 10.1111/j.1600-0897.2010.00877.x.
21. [21] Wyatt, S.M., Kraus, F.T., Roh, C.R., Elchalal, U., Nelson, D.M., Sadovsky, Y., The correlation between sampling site and gene expression in the term human placenta. Placenta 26:5 (2005), 372–379, 10.1016/j.placenta.2004.07.003.
22. [22] Matsumoto, M., Funami, K., Tanabe, M., Oshiumi, H., Shingai, M., Seto, Y., Yamamoto, A., Seya, T., Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171:6 (2003), 3154–3162.
23. [23] Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K., Seya, T., Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293:5 (2002), 1364–1369, 10.1016/S0006-291X(02)00380-7.
24. [24] Murakami, Y., Fukui, R., Motoi, Y., Kanno, A., Shibata, T., Tanimura, N., Saitoh, S., Miyake, K., Roles of the cleaved N-terminal TLR3 fragment and cell surface TLR3 in double-stranded RNA sensing. J. Immunol. 193:10 (2014), 5208–5217, 10.4049/jimmunol.1400386.
25. [25] Jensen, S., Thomsen, A.R., Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J. Virol. 86:6 (2012), 2900–2910, 10.1128/JVI.05738-11.
26. [26] Chattopadhyay, S., Sen, G.C., dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects. J. Interferon Cytokine Res. 34:6 (2014), 427–436, 10.1089/jir.2014.0034.
27. [27] Matsumoto, M., Funami, K., Oshiumi, H., Seya, T., Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol. Immunol. 48:3 (2004), 147–154.
28. [28] Schroder, M., Bowie, A.G., TLR3 in antiviral immunity: key player or bystander?. Trends Immunol. 26:9 (2005), 462–468, 10.1016/j.it.2005.07.002.
29. [29] Cardenas, I., Means, R.E., Aldo, P., Koga, K., Lang, S.M., Booth, C.J., Manzur, A., Oyarzun, E., Romero, R., Mor, G., Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J. Immunol. 185:2 (2010), 1248–1257, 10.4049/jimmunol.1000289.
30. [30] Koga, K., Cardenas, I., Aldo, P., Abrahams, V.M., Peng, B., Fill, S., Romero, R., Mor, G., Activation of TLR3 in the trophoblast is associated with preterm delivery. Am. J. Reprod. Immunol. 61:3 (2009), 196–212, 10.1111/j.1600-0897.2008.00682.x.
31. [31] Racicot, K., Kwon, J.Y., Aldo, P., Abrahams, V., El-Guindy, A., Romero, R., Mor, G., Type I interferon regulates the placental inflammatory response to bacteria and is targeted by virus: mechanism of polymicrobial infection-induced preterm birth. Am. J. Reprod. Immunol. 75:4 (2016), 451–460, 10.1111/aji.12501.
32. [32] Abrahams, V.M., Bole-Aldo, P., Kim, Y.M., Straszewski-Chavez, S.L., Chaiworapongsa, T., Romero, R., Mor, G., Divergent trophoblast responses to bacterial products mediated by TLRs. J. Immunol. 173:7 (2004), 4286–4296.
33. [33] Carey, J.C., Klebanoff, M.A., Hauth, J.C., Hillier, S.L., Thom, E.A., Ernest, J.M., Heine, R.P., Nugent, R.P., Fischer, M.L., Leveno, K.J., Wapner, R., Varner, M., Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National institute of child health and human development network of maternal-fetal medicine units. N. Engl. J. Med. 342:8 (2000), 534–540, 10.1056/NEJM200002243420802.
34. [34] Klebanoff, M.A., Carey, J.C., Hauth, J.C., Hillier, S.L., Nugent, R.P., Thom, E.A., Ernest, J.M., Heine, R.P., Wapner, R.J., Trout, W., Moawad, A., Leveno, K.J., Miodovnik, M., Sibai, B.M., Van Dorsten, J.P., Dombrowski, M.P., O'Sullivan, M.J., Varner, M., Langer, O., McNellis, D., Roberts, J.M., Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N. Engl. J. Med. 345:7 (2001), 487–493, 10.1056/NEJMoa003329.
35. [35] Macones, G.A., Parry, S., Nelson, D.B., Strauss, J.F., Ludmir, J., Cohen, A.W., Stamilio, D.M., Appleby, D., Clothier, B., Sammel, M.D., Jeffcoat, M., Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am. J. Obstet. Gynecol., 202(2), 2010, 10.1016/j.ajog.2009.10.892 147 e1-8. doi:S0002-9378(09)02118-8 [pii].
36. [36] Michalowicz, B.S., Hodges, J.S., DiAngelis, A.J., Lupo, V.R., Novak, M.J., Ferguson, J.E., Buchanan, W., Bofill, J., Papapanou, P.N., Mitchell, D.A., Matseoane, S., Tschida, P.A., Treatment of periodontal disease and the risk of preterm birth. N. Engl. J. Med. 355:18 (2006), 1885–1894, 10.1056/NEJMoa062249 doi:355/18/1885 [pii].
37. [37] Newnham, J.P., Newnham, I.A., Ball, C.M., Wright, M., Pennell, C.E., Swain, J., Doherty, D.A., Treatment of periodontal disease during pregnancy: a randomized controlled trial. Obstet. Gynecol. 114:6 (2009), 1239–1248, 10.1097/AOG.0b013e3181c15b40 00006250-200912000-00013 [pii].
38. [38] Offenbacher, S., Beck, J.D., Jared, H.L., Mauriello, S.M., Mendoza, L.C., Couper, D.J., Stewart, D.D., Murtha, A.P., Cochran, D.L., Dudley, D.J., Reddy, M.S., Geurs, N.C., Hauth, J.C., Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet. Gynecol. 114:3 (2009), 551–559, 10.1097/AOG.0b013e3181b1341f 00006250-200909000-00011 [pii].